Diagnosis and Management of Pulmonary Arterial Hypertension using MR Imaging

被引:7
|
作者
Iwasawa, Tae [1 ]
机构
[1] Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2368651, Japan
关键词
lung; MRI; pulmonary hypertension; CARDIAC MAGNETIC-RESONANCE; RIGHT-VENTRICULAR MASS; QUANTITATIVE ASSESSMENT; DYNAMIC PERFUSION; FLOW MEASUREMENT; PRESSURE; ENHANCEMENT; FIBROSIS; QUANTIFICATION; CAPABILITY;
D O I
10.2463/mrms.2012-0040
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Pulmonary arterial hypertension (PAH) is a syndrome that results from restricted blood flow through the pulmonary arterial circulation, which leads to a pathological increase in pulmonary vascular resistance (PVR) and ultimately to right heart failure. The prognosis of patients with PAH has improved with the recent development of new medications. The need for new noninvasive diagnostic tools is increasing. Magnetic resonance (MR) imaging is the gold standard for assessing the right ventricle (RV). Its high degree of reproducibility makes it ideal for monitoring changes in RV parameters in response to therapy. MR imaging can also provide both anatomical and functional information about pulmonary hemodynamics. This article reviews the current status of MR imaging of the right side of the heart and pulmonary circulation in patients with PAH and other associated pulmonary diseases.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] The pharmacologic management of pulmonary arterial hypertension
    DeBellis, Denise
    Milkin, Tamara
    Nichols, Jake
    FORMULARY, 2007, 42 (05) : 287 - +
  • [42] Sitaxsentan in the management of pulmonary arterial hypertension
    Benedict, Neal J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (04) : 363 - 368
  • [43] Correction to: Management of Pulmonary Arterial Hypertension
    Jennalyn D. Mayeux
    Irene Z. Pan
    John Dechand
    Joshua A. Jacobs
    Tara L. Jones
    Stephen H. McKellar
    Emily Beck
    Nathan D. Hatton
    John J. Ryan
    Current Cardiovascular Risk Reports, 2021, 15
  • [44] Evaluation and management of pulmonary arterial hypertension
    Beshay, Sarah
    Sahay, Sandeep
    Humbert, Marc
    RESPIRATORY MEDICINE, 2020, 171
  • [45] Management of Severe Pulmonary Arterial Hypertension
    Granton, John
    Mercier, Olaf
    De Perrot, Marc
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 700 - 713
  • [46] Advances in the management of pulmonary arterial hypertension
    Deshwal, Himanshu
    Weinstein, Tatiana
    Sulica, Roxana
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (07) : 1270 - 1280
  • [47] Ambrisentan for the management of pulmonary arterial hypertension
    Cheng, Judy W. M.
    CLINICAL THERAPEUTICS, 2008, 30 (05) : 825 - 833
  • [48] Management of Pulmonary Arterial Hypertension in the ICU
    Torbic, Heather
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (03) : 303 - 313
  • [49] Clinical management of pulmonary arterial hypertension
    Fernandez Chamorro, Felipe Nery Gervacio
    Medina, D.
    Melgarejo, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 114 - 115
  • [50] Management of Pulmonary Arterial Hypertension in Children
    Roofthooft, M. T. R.
    van Loon, R. L. E.
    Berger, R. M. F.
    PAEDIATRIC RESPIRATORY REVIEWS, 2010, 11 (04) : 240 - 245